Cargando…

Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis

OBJECTIVES: To describe oral complementary medicine (CM) use in people with inflammatory arthritis, associations with use, and changes in use over time. METHODS: Demographic, clinical, and patient-reported outcome data from 5,630 participants with rheumatoid arthritis (RA), ankylosing spondylitis (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Fletcher, Ashley, Lassere, Marissa, March, Lyn, Hill, Catherine, Carroll, Graeme, Barrett, Claire, Buchbinder, Rachelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293745/
https://www.ncbi.nlm.nih.gov/pubmed/32565819
http://dx.doi.org/10.1155/2020/6542965
_version_ 1783546352460890112
author Fletcher, Ashley
Lassere, Marissa
March, Lyn
Hill, Catherine
Carroll, Graeme
Barrett, Claire
Buchbinder, Rachelle
author_facet Fletcher, Ashley
Lassere, Marissa
March, Lyn
Hill, Catherine
Carroll, Graeme
Barrett, Claire
Buchbinder, Rachelle
author_sort Fletcher, Ashley
collection PubMed
description OBJECTIVES: To describe oral complementary medicine (CM) use in people with inflammatory arthritis, associations with use, and changes in use over time. METHODS: Demographic, clinical, and patient-reported outcome data from 5,630 participants with rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), and juvenile idiopathic arthritis (JIA) were extracted from the Australian Rheumatology Association Database (ARAD), a national observational database. CM use at entry into ARAD was ascertained for participants recruited between 2002 and 2018. CM was categorised according to the NIH/Cochrane schema (fatty acids, herbs, or supplements). Logistic regression was used to assess associations between demographic characteristics and CM use. Change in CM use between 2006 and 2016 was investigated using a nonparametric test for trend of rate by year. RESULTS: 2,156 (38.3%) ARAD participants were taking CM at enrolment (RA: 1,502/3,960 (37.9%), AS: 281/736 (38.2%), PsA: 334/749 (44.6%), and JIA: 39/185 (21.1%)). CM use was more prevalent in women (OR 1.3; 95% CI: 1.13-1.50), those with tertiary education (OR 1.32; 95% CI: 1.13-1.55), private health insurance (OR 1.26; (95% CI: 1.10-1.44), drinking alcohol sometimes (OR 1.22; 95% CI: 1.05-1.43), poorer function (HAQ) (OR 1.13; 95% CI: 1.02-1.24), use of NSAID (OR 1.32; 95% CI 1.17-1.50), weak (OR 1.21; 95% CI 1.05-1.41) but not strong opioids, and less prevalent in current smokers (OR 0.76; 95%: CI 0.63-0.91). CM use was not associated with pain, disease activity, or quality of life. The most common CMs were fish oils (N = 1,489 users) followed by glucosamine (N = 605). Both declined in use over time between 2006 and 2016 (27.5% to 21.4%, trend p = 0.85 and 15.5% to 6.4%, trend p < 0.01), respectively. CONCLUSION: Oral CM use is common among Australians with inflammatory arthritis. Its use is greater among women and those with tertiary education. Fish oil and glucosamine, the most common CMs, both declined in use over time.
format Online
Article
Text
id pubmed-7293745
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-72937452020-06-18 Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis Fletcher, Ashley Lassere, Marissa March, Lyn Hill, Catherine Carroll, Graeme Barrett, Claire Buchbinder, Rachelle Int J Rheumatol Research Article OBJECTIVES: To describe oral complementary medicine (CM) use in people with inflammatory arthritis, associations with use, and changes in use over time. METHODS: Demographic, clinical, and patient-reported outcome data from 5,630 participants with rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), and juvenile idiopathic arthritis (JIA) were extracted from the Australian Rheumatology Association Database (ARAD), a national observational database. CM use at entry into ARAD was ascertained for participants recruited between 2002 and 2018. CM was categorised according to the NIH/Cochrane schema (fatty acids, herbs, or supplements). Logistic regression was used to assess associations between demographic characteristics and CM use. Change in CM use between 2006 and 2016 was investigated using a nonparametric test for trend of rate by year. RESULTS: 2,156 (38.3%) ARAD participants were taking CM at enrolment (RA: 1,502/3,960 (37.9%), AS: 281/736 (38.2%), PsA: 334/749 (44.6%), and JIA: 39/185 (21.1%)). CM use was more prevalent in women (OR 1.3; 95% CI: 1.13-1.50), those with tertiary education (OR 1.32; 95% CI: 1.13-1.55), private health insurance (OR 1.26; (95% CI: 1.10-1.44), drinking alcohol sometimes (OR 1.22; 95% CI: 1.05-1.43), poorer function (HAQ) (OR 1.13; 95% CI: 1.02-1.24), use of NSAID (OR 1.32; 95% CI 1.17-1.50), weak (OR 1.21; 95% CI 1.05-1.41) but not strong opioids, and less prevalent in current smokers (OR 0.76; 95%: CI 0.63-0.91). CM use was not associated with pain, disease activity, or quality of life. The most common CMs were fish oils (N = 1,489 users) followed by glucosamine (N = 605). Both declined in use over time between 2006 and 2016 (27.5% to 21.4%, trend p = 0.85 and 15.5% to 6.4%, trend p < 0.01), respectively. CONCLUSION: Oral CM use is common among Australians with inflammatory arthritis. Its use is greater among women and those with tertiary education. Fish oil and glucosamine, the most common CMs, both declined in use over time. Hindawi 2020-06-05 /pmc/articles/PMC7293745/ /pubmed/32565819 http://dx.doi.org/10.1155/2020/6542965 Text en Copyright © 2020 Ashley Fletcher et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Fletcher, Ashley
Lassere, Marissa
March, Lyn
Hill, Catherine
Carroll, Graeme
Barrett, Claire
Buchbinder, Rachelle
Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis
title Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis
title_full Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis
title_fullStr Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis
title_full_unstemmed Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis
title_short Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis
title_sort oral complementary medicine use among people with inflammatory arthritis: an australian rheumatology association database analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293745/
https://www.ncbi.nlm.nih.gov/pubmed/32565819
http://dx.doi.org/10.1155/2020/6542965
work_keys_str_mv AT fletcherashley oralcomplementarymedicineuseamongpeoplewithinflammatoryarthritisanaustralianrheumatologyassociationdatabaseanalysis
AT lasseremarissa oralcomplementarymedicineuseamongpeoplewithinflammatoryarthritisanaustralianrheumatologyassociationdatabaseanalysis
AT marchlyn oralcomplementarymedicineuseamongpeoplewithinflammatoryarthritisanaustralianrheumatologyassociationdatabaseanalysis
AT hillcatherine oralcomplementarymedicineuseamongpeoplewithinflammatoryarthritisanaustralianrheumatologyassociationdatabaseanalysis
AT carrollgraeme oralcomplementarymedicineuseamongpeoplewithinflammatoryarthritisanaustralianrheumatologyassociationdatabaseanalysis
AT barrettclaire oralcomplementarymedicineuseamongpeoplewithinflammatoryarthritisanaustralianrheumatologyassociationdatabaseanalysis
AT buchbinderrachelle oralcomplementarymedicineuseamongpeoplewithinflammatoryarthritisanaustralianrheumatologyassociationdatabaseanalysis